Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
The Medical Journal of Australia|October 16, 1989
Deaths associated with diabetic ketoacidosis and hyperosmolar coma. 1973-1988P S Hamblin, D J Topliss, N Chosich, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferasesJ W Barlow, L E Raggatt, C F Lim, et al.
Clinical Endocrinology|May 1, 1987
Evaluation of T4 and T3 binding kinetics in the thyroxine binding globulin abnormality of Australian aboriginesV S Mohr, J W Barlow, D J Topliss, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serumC F Lim, A J Curtis, J W Barlow, et al.
The Journal of Pharmacy and Pharmacology|November 1, 1986
Non-isotopic spectrophotometric determination of the unbound fraction of drugs in serumC F Lim, K N Wynne, J M Barned, et al.
Thyroid : Official Journal of the American Thyroid Association|August 1, 1995
Influence of nonesterified fatty acids and lysolecithins on thyroxine binding to thyroxine-binding globulin and transthyretinC F Lim, S L Munro, K N Wynne, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitroC F Lim, N M Loidl, J A Kennedy, et al.
Clinical Endocrinology|April 1, 1987
Effect of oral frusemide on diagnostic indices of thyroid functionH H Newnham, P S Hamblin, F Long, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1981
Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albuminJ R Stockigt, D J Topliss, J W Barlow, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3'-triiodothyronine in human hepatoblastoma cellsT C Crowe, N L Cowen, N M Loidl, et al.
Pageof 10